CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease
Open accessThe DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Abstract
There is no consensus on the exact role of the adaptive immune system in Parkinson’s disease pathogenesis, although there is increasing evidence that it is somehow involved. Moreover, T cell infiltration in the brain has not been thoroughly studied in Parkinson’s disease and no study has assessed the infiltration in incidental Lewy body diseases cases that are considered to be early presymptomatic stages of the disease. In this study, we performed an immunohistochemistry/immunofluorescence quantitative and phenotypic assessment of T cell infiltration in human substantia nigra pars compacta and analysed the correlations with neuronal death and synucleinopathy throughout different stages of the disease. We included two groups of incidental Lewy disease in the study. One of the groups, which is believed to be the earliest stage of the disease, showed α-synuclein aggregates only in the olfactory bulb. The second group also presented α-synuclein aggregates in the substantia nigra. We also assessed the formation of different α-synuclein aggregates throughout the different stages of the unified staging system for Lewy body disorders (I to IV). We found that CD8 T cells were increased in diagnosed Parkinson’s disease cases compared to the control group and their density positively correlated with neuronal death. Some of the infiltrating CD8 T cells were indeed contacting dopaminergic neurons. No differences were found regarding CD4 T cells. In the earliest stage of the disease, when substantia nigra α-synuclein aggregation is absent, we found a robust CD8 T cell infiltration and no dopaminergic neuronal death yet. Conversely, in the next stage we found neuronal loss and a milder CD8 T cell infiltration. CD8 T cell infiltration paralleled that of α-synuclein accumulation and neuronal death throughout stages II to IV. We also confirmed that CD8 T cells in charge of immune surveillance and involved in the aetiopathogenesis of the disease are equipped with cytolytic enzymes (granzyme A, B and K) and/or proinflammatory cytokines (interferon gamma), and that phenotypic differences were observed between early and late stages of the disease. We also demonstrate that a high proportion of nigral CD8 T cells are tissue resident memory T cells. Our results show that nigral cytotoxic CD8 T cell infiltration is an earlier pathogenic event than α-synuclein aggregation and neuronal death and that it parallels the progression of neuronal death and synucleinopathy in Parkinson’s disease. Overall, our study suggests that CD8 T cell cytotoxic attack may initiate and propagate neuronal death and synucleinopathy in Parkinson’s disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other authors have demonstrated that cytotoxic CD8 + T cell infiltration occurred earlier than a-synuclein aggregation and neuronal death, suggesting adaptive immune system involvement.87”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [87]
Citations
Cites
1 retracted
Chandra, G., Rangasamy, S. B., Roy, A., Kordower, J. H., & Pahan, K. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.714824 · Cited by 90
RetractedStaging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738
Perforin and granzymes: function, dysfunction and human pathology
Voskoboinik, I., Whisstock, J. C., & Trapani, J. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3839 · Cited by 1,327
Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
Castro, F., Cardoso, A. P., Gonçalves, R. M., Serre, K., & Oliveira, M. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00847 · Cited by 1,224
Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172
T cells from patients with Parkinson’s disease recognize α-synuclein peptides
Sulzer, D., Alcalay, R. N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W. H., Mao, X., et al. (2017) · Nature · doi:10.1038/nature22815 · Cited by 866
Hamza, T. H., Zabetian, C. P., Tenesa, A., Laederach, A., Montimurro, J., Yearout, D., Kay, D. M., Doheny, K. F., Paschall, J., Pugh, E., et al. (2010) · Nature Genetics · doi:10.1038/ng.642 · Cited by 784
the Arizona Parkinson’s Disease Consortium, Beach, T. G., Adler, C. H., Lue, L., Sue, L. I., Bachalakuri, J., Henry-Watson, J., Sasse, J., Boyer, S., Shirohi, S., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0538-8 · Cited by 698
Understanding Dopaminergic Cell Death Pathways in Parkinson Disease
Michel, P. P., Hirsch, E. C., & Hunot, S. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.038 · Cited by 600
Research works printed but not linked: 1
- Mosley, 2012, Inflammation and adaptive immunity in Parkinson’s disease. Cold Spring Harb, Perspect Med, 2, 1
Cited by
Items 101–200 of 292
α-Synuclein orchestrates Th17 responses as antigen and adjuvant in Parkinson’s disease
Furusawa-Nishii, E., Солонго, Б., Rai, K., Yoshikawa, S., Chiba, A., Okuzumi, A., Ueno, S., Hoshino, Y., Imamichi, Y., Kimura, H., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03359-w · Cited by 19
“Since the identification of T cells in autop-sied brains of synucleinopathy patients [4–6], the role of T cells in neurodegeneration has attracted increasing attention.”
Immunological aspects of central neurodegeneration
Niso‐Santano, M., Fuentes, J. M., & Galluzzi, L. (2024) · Cell Discovery · doi:10.1038/s41421-024-00666-z · Cited by 21
Spicer, J. A., Huttunen, K. M., Jose, J., Dimitrov, I., Akhlaghi, H., Sutton, V. R., Voskoboinik, I., & Trapani, J. A. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01338 · Cited by 18
Mercado, G., Käufer, C., Richter, F., & Peelaerts, W. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-240195 · Cited by 20
Bendig, J., Frank, A. K., & Reichmann, H. (2024) · Ageing and Neurodegenerative Diseases · doi:10.20517/and.2023.36 · Cited by 18
Inflammation and heterogeneity in synucleinopathies
Freuchet, A., Pinçon, A., Sette, A., & Arlehamn, C. S. L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1432342 · Cited by 16
Mix, M. R., Kreitlow, B. L., Berton, R. R., Xu, J., Fain, C. E., van de Wall, S., Pewe, L. L., Hancox, L. S., Hassert, M., Kannan, S. K., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02174-y · Cited by 16
Blasco-Agell, L., Pons‐Espinal, M., Testa, V., Roch, G., Montero-Muñoz, J., Fernández‐Carasa, I., Baruffi, V., González-Sepúlveda, M., Richaud‐Patín, Y., Jiménez‐Delgado, S., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08544-4 · Cited by 15
Self-citationParkinson’s Disease-Specific Autoantibodies against the Neuroprotective Co-Chaperone STIP1
Tan, J. S. Y., Lee, B. T. K., Lim, J., Ma, D., Goh, J. X., Goh, S. Y., Gulam, M. Y., Koh, S. M., Lee, W. W., Feng, L., et al. (2022) · Cells · doi:10.3390/cells11101649 · Cited by 15
The major histocompatibility complex participates in Parkinson’s disease
Gu, R., Pan, J., Awan, M. U. N., Sun, X., Fang, Y., Bai, L., & Bai, J. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107168 · Cited by 15
Evolving insights into erythrocytes in synucleinopathies
Yang, Y., Nie, X., Wang, Y., Sun, J., Gao, X., & Zhang, J. (2024) · Trends in Neurosciences · doi:10.1016/j.tins.2024.06.005 · Cited by 15
Recinto, S. J., Kazanova, A., Liu, L., Cordeiro, B., Premachandran, S., Bessaiah, H., Allot, A., Afanasiev, E., Mukherjee, S., Pei, J., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-00945-w · Cited by 16
“Mice DAT-Ires-Cre (RRID:IMSR_JAX:006660) mice were bred with Ai9 mice(RRID: IMSR_JAX:007909) to induce the expressionof tdTomato in DAT-expressing cells (DAT-tdTomato) then were crossed with PINK1-de fi cient (PINK1 KO) mice in a mixed B6.”
Immunosuppressants contribute to a reduced risk of Parkinson’s disease in rheumatoid arthritis
Guo, X., Li, C., Zhang, X., & Li, R. (2022) · International Journal of Epidemiology · doi:10.1093/ije/dyac085 · Cited by 15
Recent advances in Alzheimer’s disease: From molecular mechanisms to therapeutic strategies
Rudman, M. D., Ulrich, J. D., & Holtzman, D. M. (2026) · Cell · doi:10.1016/j.cell.2026.06.006 · Cited by 18
Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells
Vega-Benedetti, A. F., Porcedda, C., Ercoli, T., Fusco, G., Burgaletto, C., Pillai, R., Palmas, F., Cantone, A. F., Angius, F., Solla, P., et al. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12554-3 · Cited by 15
Kršek, A., Schleicher, L. M. S., Jagodic, A., & Batičić, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189178 · Cited by 16
“This is often accompanied by BBB disruption, allowing peripheral cytokines, immune cells, and microbial byproducts to gain access to the CNS. Importantly, PD-associated inflammation is not restricted to the brain [63].”
Webster, J. M., Yang, Y.-T., Miller, A. T., Zane, A., Scholz, K., Stone, W. J., Mudium, N., Corbin-Stein, N. J., Won, W.-J., Stoll, A. C., et al. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107323 · Cited by 15
Zhang, P., Zhao, L., Li, H., Shen, J., Li, H., & Xing, Y. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1083928 · Cited by 14
“Notably, a high proportion of substantia nigra CD8 T-cell infiltration has been considered an early alteration in PD, even occurring before death of dopamine neuronal cells and α-synuclein aggregation, which is also associated with progression of PD (Galiano-Landeira et al., 2020).”
BackgroundXie, Y., Chen, L., Chen, J., & Chen, Y. (2024) · Brain and Behavior · doi:10.1002/brb3.3373 · Cited by 13
“Peripheral T cells have a profound impact on PD. Postmortem and in vivo studies both revealed that T cells are present in the PD brain (Galiano-Landeira et al., 2020; Williams et al., 2021).”
BackgroundAlterations of Peripheral Lymphocyte Subsets in Isolated Rapid Eye Movement Sleep Behavior Disorder
Zheng, Y., Li, Y., Cai, H., Kou, W., Chen, Y., Li, S., Wang, J., Zhang, N., & Feng, T. (2024) · Movement Disorders · doi:10.1002/mds.29798 · Cited by 12
Aziz, N., Wal, P., Patel, A., & Prajapati, H. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03109-4 · Cited by 13
“…gene increases the vulnerability of neurons to CD8 + T cell interaction once it reaches the cell surface (Unger et al. 2020) (Coque et al. 2019) (Galiano-Landeira et al. 2020), and NOD2 gene increases the expression of pro-inflammatory cytokinin, the creation of type I IFNs, and the initiation…”
Perdaens, O., & Pesch, V. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312637 · Cited by 13
Wu, Z., Hu, Z., Gao, Y., Xia, Y., Zhang, X., & Jiang, Z. (2023) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2022.1095676 · Cited by 13
“The infiltration of cytotoxic CD8 + T cell in the substantia nigra takes place before α-synuclein aggregation and neuronal death, and it parallels the progression of neuronal death and synuclein disease in PD (Galiano-Landeira et al., 2020).”
Backgroundde Fàbregues, O., Sellés, M. C., Ramos-Vicente, D., Roch, G., Vila, M., & Bové, J. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106308 · Cited by 12
“Both CD4 and CD8 T cells not only reside in the meninges but also populate the perivascular spaces and, to a lesser extent, the CNS parenchyma of different brain regions, including the SNpc (Fransen et al., 2020; Galiano-Landeira et al., 2020; MachadoSantos et al., 2018; Smolders et al., 2018, 2013).”
BackgroundResultInfluentialSelf-citationTDP-43 pathology induces CD8 + T cell activation through cryptic epitope recognitionPreprint
Chizari, S., Zanovello, M., Kong, S. L., Saigal, V. J., Brown, A., Turchetti, V., Chen, B., Devine, C. C., Zampedri, L., Skorupinska, I., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.22.660773 · Cited by 16
Xiao, Y., Wei, Q., Ou, R., Yang, T., Jiang, Q., Hou, Y., Zhang, L., Liu, K., Wang, S., Lin, J., et al. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11790-3 · Cited by 11
“In addition, the infiltration of CD8 + T lymphocytes in the substantia nigra was detected prior to the dopaminergic neuron loss and the Lewy neurites appearance in patients with incidental Lewy disease [6].”
BackgroundLi, H., Liu, D., Li, L.-B., Zhang, Y., Dong, H., Rong, H., Zhang, J., Wang, J.-P., Jin, M., Luo, N., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117319 · Cited by 13
Srivastava, P., Nishiyama, S., Zhou, F., Lin, S., Srivastava, A., Su, C., Xu, Y., Peng, W., Levy, M., Schwarzschild, M. A., et al. (2023) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-023-10094-7 · Cited by 13
“Studies have reported increased infiltration of cytotoxic CD8 + T cells and little or no change in CD4 + T cells in PD patients and in MPTP models (Galiano-Landeira et al. 2020 ; Schröder et al. 2018) of PD.”
BackgroundT-cell based immunotherapies for Parkinson’s disease
Pacheco, R. (2021) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2021.00007 · Cited by 15
“00007 Page 75 In later stages of the pathology, these authors found a lower CD8+ T-cell infiltration associated to neuronal loss and accumulation of αSyn aggregates in the SN [28].”
BackgroundInfluentialNeurons upregulate PD-L1 via IFN/STAT1/IRF1 to alleviate damage by CD8+ T cells in cerebral malaria
Wang, Y., Shen, Y., Liang, J., Wang, S., Huang, Y., Zhu, Q., Zhang, X., Yu, K., Tong, G., Yang, C., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03114-7 · Cited by 11
“CD8 + T cells directly target cells through an immunological synapse comprising the T-cell receptor, MHC-I molecules, and adhesion molecules, resulting in target cell damage [39, 57–59].”
BackgroundChen, Z., Li, W., Meng, B., Xu, C., Huang, Y., Li, G., Wen, Z., Liu, J., & Mao, Z. (2024) · iScience · doi:10.1016/j.isci.2024.110243 · Cited by 14
Guevara‐Salinas, A., Netzahualcoyotzi, C., Álvarez‐Luquín, D. D., Pérez‐Figueroa, E., Sevilla-Reyes, E. E., Castellanos‐Barba, C., Vega-Angeles, V. T., Terán‐Dávila, E., Estudillo, E., Velasco, I., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14883 · Cited by 12
“The shift of microglia to an in - flammatory or M1 phenotype results in increased infiltration of both CD4 + and CD8 + T lymphocytes into the CNS, reaching the SNpc. 5,6 Increased production of reactive oxygen species (ROS) and reactive nitrogen species (NOS) is also observed due to the stress caused by neuronal death…”
BackgroundCD8 + T cell infiltration and proliferation in the brainstem during experimental cerebral malaria
Wang, J., Zhu, Q., Shen, Y., Liang, J., Wang, Y., Huang, Y., Tong, G., Wang, X., Zhang, N., Yu, K., et al. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14431 · Cited by 12
“18,19 Therefore, in addition to the beneficial anti-infection effects of the pro-inflammatory response, suppression of neuroinflammation is equally essential for limiting tissue damage and preserving neu - rological function.”
BackgroundChew, G., Mai, A. S., Ouyang, J. F., Qi, Y., Chao, Y., Wang, Q., Petretto, E. G., & Tan, E. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00698-y · Cited by 10
Sardoiwala, M. N., Biswal, L., & Choudhury, S. R. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c18226 · Cited by 10
Single-cell sequencing insights into the transcriptional landscape of Parkinson's disease
Su, Y., Zheng, H., Cui, X., Zhang, S., Zhang, S., Hu, Z., Hao, X., Li, M., Guo, G., Xia, Z., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102553 · Cited by 10
Ayerra, L., Abellanas, M. A., Vidaurre, C., Basurco, L., Tavira, A., Luquin, E., Clavero, P., Mengual, E., Collantes, M., Peñuelas, I., et al. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.04.037 · Cited by 10
Moiseyenko, A., Antonello, G., Schonhoff, A. M., Boktor, J. C., Long, K., Dirks, B., Oguienko, A. D., Winnett, A. V., Simpson, P., Daeizadeh, D., et al. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-026-01287-x · Cited by 9
Immune signaling and function in neurodegeneration
Latour, Y. L., & McGavern, D. B. (2026) · Journal of Clinical Investigation · doi:10.1172/jci199850 · Cited by 10
“related with neuronal death, although it remains uncertain whether this is causative or reactive (158). α-syn–specific T cells emerge in the blood before motor symptoms in PD, peak soon after symptom onset, and decline as disease progresses.”
Causal role of immune cells on risk of Parkinson’s disease: a Mendelian randomization study
Gu, J. H., Qiao, Y., & Cong, S. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1368374 · Cited by 10
The neuroinflammation collection: a vision for expanding neuro-immune crosstalk inBrain
Irani, S. R., Nath, A., & Zipp, F. (2021) · Brain · doi:10.1093/brain/awab187 · Cited by 10
“Hence, a Brain paper describing a robust CD8 + T cell infiltration into the substantia nigra pars compacta of Parkinson’s disease brains was a major breakthrough.(10) These T cells expressed directly cytolytic factors, including granzymes (serine proteases released by cytoplasmic granules), in addition to pro-inflamma…”
BackgroundXiao, Y., Ma, Y., & Shang, H. (2025) · Neuroepidemiology · doi:10.1159/000545314 · Cited by 9
Freeman, S. A., Ayoub, I., Dauvilliers, Y. A., & Liblau, R. (2025) · Seminars in Immunology · doi:10.1016/j.smim.2025.101962 · Cited by 8
Single-cell transcriptomics for immune profiling of cerebrospinal fluid in neurological diseases
Ramos-Vicente, D., Monterosso, P., de Fàbregues, O., Roch, G., Vila, M., & Bové, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1599303 · Cited by 10
Self-citationLeite, A. D. O. F., Bento‐Torres, J., dos Reis, R. R., Sobral, L. L., de Souza, A. C. P., Trévia, N., de Oliveira, R. B., Lins, N. A. D. A., Diniz, D. G., Diniz, J. A. P., et al. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.749595 · Cited by 8
Adaptive immunity in the pathogenesis and treatments of Parkinson’s disease
Du, X., Akter, S., Oludipe, D. B., Sil, S., Zhang, C., Gendelman, H. E., & Mosley, R. L. (2025) · NeuroImmune Pharmacology and Therapeutics · doi:10.1515/nipt-2025-0008 · Cited by 8
“…early in the disease course, even before detectable α -synuclein ( α -syn) aggregation and dopaminergic neuron loss and express cytotoxic molecules such as granzyme A/B and IFN-γ , suggesting that adaptive immune responses may contribute to the initiation or progression of neurodegeneration [4].”
Mask on, Mask off: Subclinical Parkinson’s Disease Unveiled by COVID-19
Beckers, M., Bloem, B. R., & Helmich, R. C. G. (2022) · Journal of Movement Disorders · doi:10.14802/jmd.22067 · Cited by 8
Bérard, M., Martínez-Drudis, L., Sheta, R., El‐Agnaf, O. M. A., & Oueslati, A. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00683-8 · Cited by 8
“Indeed, converging lines of evidence from post-mortem clinical observations [89–91] and α-syn-based animal models of PD [90, 92, 93] reported the presence of infiltrating peripheral adaptive immune cells, specifically CD3 + , CD4 + and CD8 + T cells, in PD-diseased brains and in close proximity to…”
BackgroundTargeting neuroinflammation in neurodegenerative disorders: the emerging potential of semaglutide
Evola, V., & Parmar, M. S. (2026) · Inflammation Research · doi:10.1007/s00011-025-02166-6 · Cited by 8
“Immunologically, PD is marked by a stronger adaptive immune component, including significant infiltration of CD8 + T-cells, and a specific pattern of glial activation that shapes its inflammatory microenvironment [57, 58 ] .”
Li, L., Gao, W., Ren, N., & Chen, L. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111273 · Cited by 7
Abhilash, P. L., Bharti, U., Rashmi, S. K., Philip, M., Raju, T. R., Kutty, B. M., Sagar, B. K. C., & Alladi, P. A. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01528-8 · Cited by 9
“PD is characterized by T-cell infiltration (Galiano-Landeira et al., 2020; Subbarayan et al., 2020; Seo et al., 2020), microgliosis (Joers et al. 2017; review), and astrogliosis (Croisier and Graeber 2006), all of which affect the survival of substantia nigra neurons.”
Microglia and Systemic Immunity
Jucá, P. M., Duque, É. D. A., Covre, L. H. H., Albernaz-Mariano, K. A., & Munhoz, C. D. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-55529-9_16 · Cited by 7
Yao, X., Wang, P., Huang, Z., & Li, L. (2025) · BMC Neurology · doi:10.1186/s12883-025-04388-x · Cited by 6
“The development of PD is associated with the activation of both microglia [6, 7] and T cells [8, 9], indicating the involvement of innate and adaptive immune responses.”
Increased Numbers of CD4 + T‐Cells in the Hypocretin/Orexin Region of Narcolepsy Type 1
Shan, L., Fonville, M., Hoekstra, M., Fronczek, R., Smolders, J., & Swaab, D. F. (2026) · Annals of Neurology · doi:10.1002/ana.78199 · Cited by 7
Yang, M., Ke, L., Geng, Y., Hu, P., Qiu, Y., Liu, Z., Zhang, X., Wan, F., Jacob, J. A., & Liao, J. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s526777 · Cited by 6
Abdelwahab, T., Stadler, D., Knöpper, K., Arampatzi, P., Saliba, A., Kastenmüller, W., Martini, R., & Groh, J. (2023) · iScience · doi:10.1016/j.isci.2023.106698 · Cited by 8
Zaichick, S., & Caraveo, G. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1292555 · Cited by 6
Fredlund, F., Jiménez-Ferrer, I., Grabert, K., Belfiori-Carrasco, L. F., Luk, K. C., & Swanberg, M. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-240062 · Cited by 7
imply: improving cell-type deconvolution accuracy using personalized reference profiles
Meng, G., Pan, Y., Tang, W., Zhang, L., Cui, Y., Schumacher, F. R., Wang, M., Wang, R., He, S., Krischer, J. P., et al. (2024) · Genome Medicine · doi:10.1186/s13073-024-01338-z · Cited by 6
“These findings are well-aligned with previous studies where the PD patients showed elevated CD8 proportions and reduced CD4 proportions than controls [7, 20, 26, 52].”
ResultRoss, A., Prowse, N. A., Zhang, H., Hayley, S. P., & Hongyu, S. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1627305 · Cited by 6
The Gut–brain–immune Triad in Neurodegeneration: An Integrated Perspective
Chakrabarti, S. K., & Chattopadhyay, D. (2025) · Journal of Translational Gastroenterology · doi:10.14218/jtg.2025.00027 · Cited by 16
Nguyễn, H. Đ., Tran, H. S., Nguyen, T. T., Kwak, I. H., Kim, Y. J., Ma, H., Kim, Y. E., & Kim, Y. E. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105990 · Cited by 6
Shen, X., Zheng, C., Lin, R., Wang, J., & Chen, Z. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1795042 · Cited by 5
The humoral immune landscape in Parkinson's disease: Unraveling antibody and B cell changes
Baridjavadi, Z., Mahmoudi, M., Abdollahi, N., Ebadpour, N., Mollazadeh, S., Haghmorad, D., & Esmaeili, S. (2024) · Cell Biochemistry and Function · doi:10.1002/cbf.4109 · Cited by 6
“64 This neuronal death further releases intra-cellular particles, amplifying microglia activation.”
Adaptive Immunity and Parkinson's Disease
Elyaman, W. (2025) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041639 · Cited by 5
Goldeck, D., Schulte, C., dos Santos, M. C. T., Scheller, D., Oettinger, L., Pawelec, G., Deuschle, C., Berg, D., da Costa, A. N., & Maetzler, W. (2022) · Journal of Ageing and Longevity · doi:10.3390/jal3010001 · Cited by 4
“In early PD stages, the infiltration of cytotoxic CD8+ T-cells into the substantia nigra has also been reported [40].”
BackgroundFigliomeni, A., Winter, S. J., Abonnel, M. Y., Kenna, J. E., Lodge, S., Whiley, L., Bernal, A., Coudert, J. D., Noonan, J. E., Kaskow, B. J., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01212-8 · Cited by 5
Delphinidin modulates neuroinflammation and behavioral deficits in a Parkinson’s disease mouse model
Grotemeyer, A., Alexander, S., Frieß, L., Roewer, J., Bankoglu, E. E., Badr, M., Wu, J., Stopper, H., Volkmann, J., Roewer, N., et al. (2026) · npj Parkinson s Disease · doi:10.1038/s41531-025-01244-0 · Cited by 4
Immunosenescence and inflammaging in Parkinson’s disease: mechanisms and therapeutic prospects
Yan, R., Feng, H., & Zhang, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1749278 · Cited by 5
Guso, E., Lupoli, A., Olivieri, E., Bottoni, A., Gironi, M., Missarelli, D. M., Toosy, A., Rossi, E., & Furlan, R. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.02.047 · Cited by 4
Adaptive immunity in the pathogenesis of neurodegeneration
Li, Y., Ulrich, J. D., & Holtzman, D. M. (2026) · Nature Immunology · doi:10.1038/s41590-026-02538-y · Cited by 4
“In the substantia nigra of patients with Parkinson’s disease, CD8 + T cells not only contact dopaminergic neurons, but also positively correlate with dopaminergic cell death 51 .”
Ma, L., Liu, Y., Ren, Y., Mi, N., Fang, J., Bao, R., Xu, X., Zhang, H., & Tang, Y. (2024) · European journal of medical research · doi:10.1186/s40001-024-02201-y · Cited by 4
Shi, Y., Zhao, X., Si, Y., Zhang, X., Wang, D., Yao, L., & Sun, L. (2025) · BMC Biology · doi:10.1186/s12915-025-02358-w · Cited by 4
“It is generally believed that T cells producing IFN-γ are the major cell type in the microenvironment of the PD model or post-mortem brain tissue [6, 7], which has also been supported by our research through single-cell RNA sequencing (scRNA-seq) [8].”
Tavira, A., Basurco, L., Abellanas, M. A., Ayerra, L., Vidaurre, C., Luquin, E., Vales, Á., González‐Aseguinolaza, G., Marrodán, L., Alonso, M. M., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01158-x · Cited by 5
Gut Microbes in Parkinson's Disease
Markidi, A., Elford, J. D., Berkers, C. R., Kraneveld, A. D., & Perez‐Pardo, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99971-7.00002-3 · Cited by 4
Nies, Y. H., Yahaya, M. F., Lim, W. L., & Teoh, S. L. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230608122552 · Cited by 4
Lin, Z., Zhang, J., Wu, R., Chen, G., Peng, J., Li, R., & Chen, S. (2023) · Medicine · doi:10.1097/md.0000000000035311 · Cited by 3
“[53] In addition, it was reported that “naïve” T cells, CD4 + T cells, and CD19 + B cells were reduced while cytotoxic CD8 + T cells were elevated in PD brain.”
Chowdhury, R., Hendlinger, A., Rieß, O., & Schulze-Hentrich, J. M. (2025) · Epigenomics · doi:10.1080/17501911.2025.2518909 · Cited by 3
Keleş, B. S., Rumman, B., Samarie, M. A. J. A., Özdemir, Y., Çakmak, Ö. Ö., Akyoldaş, G., Ertan, S., & Sokullu, E. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02461-z · Cited by 4
“Concurrently, infiltration of CD8 ⁺ T lymphocytes into the SNpc has been detected before dopaminergic neuron loss, indicating that cytotoxic T cells can contribute to neuronal death even prior to overt Lewy body (LB) formation [121, 122].”
Wang, L., Zhang, F., Wu, J., Yang, S., Zhou, D., Sun, X., Chang, B., Hu, B., & Zhou, Y. (2025) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70697 · Cited by 3
“This study also found that half of the CD8 + T cells expressed IFN-γ, and immunofluorescence imaging revealed granzyme B (GrzB) granules within CD8 + T cells, suggesting that the TRM in Parkinson's lesions might be potentially cytotoxic [82].”
Li, J., Lin, Y., Gao, J., Yang, F., Li, C., Chen, Y., Huang, C., Song, X., Song, Z., Wu, J., et al. (2026) · Nature Biomedical Engineering · doi:10.1038/s41551-026-01621-x · Cited by 4
Tchung, A., Even, A., & Trudeau, L. (2026) · Trends in Neurosciences · doi:10.1016/j.tins.2026.02.003 · Cited by 4
Moon, J., Moutusy, S. I., Zhang, M., Ndayisaba, A., Rodriguez, D., Kodsi, D. N. E., Kuzkina, A., Younis, S., Jahanbani, S., van Dam, L. S., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2537271123 · Cited by 3
“Previous studies have reported infiltration of CD4 + and CD8 + T cells in the brains of patients with neurodegenerative diseases, including MSA, where these cells are positioned to contribute to neuroinflammation (25, 27, 29, 31, 33, 55).”
Wójcik, P., Culmsee, C., & Adamczyk, A. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01733-7 · Cited by 3
Neglected cytotoxic T cell invasion of the brain: how specific for Parkinson’s disease?
Halliday, G. M. (2020) · Brain · doi:10.1093/brain/awaa390 · Cited by 3
Disease mechanisms as subtypes: Immune dysfunction in Parkinson's disease
Contaldi, E., Magistrelli, L., & Comi, C. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85555-6.00008-4 · Cited by 3
Tian, Y., Jiang, L., Zhang, S., Cao, Y., Liu, F., Xia, L., & Su, Z. (2022) · Authorea · doi:10.22541/au.166126875.56478352/v1 · Cited by 3
Corbin-Stein, N. J., Childers, G. M., Webster, J. M., Zane, A., Yang, Y., Ali, M. A., Sandoval, I. M., Manfredsson, F. P., Kordower, J. H., Tyrrell, D. J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.02.597035 · Cited by 3
Iyengar, A. S., Dunkley, P. R., & Dickson, P. W. (2025) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2025.578755 · Cited by 2
Neuroimmune crosstalk in Parkinson’s disease: the pivotal role of microglia and infiltrating T cells
Li, X., Sun, W., Chen, W., Wang, N., & Wang, S. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11067-0 · Cited by 2
“Furthermore, the density of infiltrating CD8 + T cells has shown a progressive increase correlating with advancing neuronal degeneration, implying that CD8 + T cell– mediated cytotoxicity may both initiate and propagate the cascade of neuronal death and PD progression [25].”
InfluentialHe, Y., Wang, J., Ying, C., Liang, W., Yin, Z., Gao, J., Wang, B., Zhao, X., & Zhang, Y. (2025) · Medicine · doi:10.1097/md.0000000000044392 · Cited by 2
“[48] In addition, adaptive immunity is involved in neuroinflammation in PD. CD3, [14] CD4, [49,50] and CD8 [51] T cells can trigger inflammation by infiltrating the CNS, and in 1988, McGeer et al found that CD3 T cells infiltrated the brains of PD patients.”
Wang, Z., & Yan, J. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1688653 · Cited by 2
Ghosh, S., Lin, H., Chu, S., Ngu, H., Zang, N., Raman, R., Stark, K. L., Foreman, O., Hashemifar, S. S., Easton, A. E., et al. (2026) · Discover Neuroscience · doi:10.1186/s13064-026-00286-1 · Cited by 2
“T-cell infiltration and BBB compromise were also detected.”
Soto-Avellaneda, A., Prigent, A., Meyerdirk, L. K., Schautz, N., Pospisilik, J. A., Brundin, L., & Henderson, M. X. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03596-z · Cited by 2
“T-cells were sparse in both cohorts, and it is possible that the affected area was missed in sectioning for the 9-month cohort.”
Kadel, S., Scheller, L., Leipold, A. M., Krammer, T., Raskó, T., Alb, M., Weis, P., Leberzammer, M., Schmitt, F., Stetter, C., et al. (2026) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-25-0278 · Cited by 3
The Impact of Antigen Presentation on BBB Disruption and Neuroinflammation
Maynes, M. A., & Johnson, A. J. (2026) · Physiology · doi:10.1152/physiol.00041.2025 · Cited by 2
DYRK1A and Parkinson’s disease, facts and hypotheses
Meijer, L., Lindberg, M. F., Hogrel, G., & Khor, B. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107379 · Cited by 3
Wang, K., Han, K., & Wang, Y. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03918-9 · Cited by 2
Mechanisms of Therapeutic Resistance and Recent Advances in Glioblastoma Treatment
Achari, E., Ahmady, F., Sharma, A., Schmidt‐Wolf, I. G. H., Maciaczyk, J., Luwor, R. B., & Achuthan, A. A. (2026) · Immunology and Cell Biology · doi:10.1111/imcb.70144 · Cited by 2
“Increased cytotoxic activity of meningeal CD8 + [10, 11] and Th 1 and Th 17 CD4 + T cells [12–14], for example, was found to drive pathogenesis in Parkinson's disease, with initiation mediated through decreasing Treg abundance at early stages [14].”
Wang, Q.-Q., Sun, Q.-Q., Guo, Y.-S., Yin, S., & Zhou, J. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00571-3 · Cited by 2
“In PD, both CD4 + and CD8 + T cells infiltrate the SN, with CD8 + T cells appearing during prodromal stages (incidental Lewy body disease) and CD4 + T cells contributing to neurodegeneration [262, 263].”
Metadata
- Authors
- Galiano-Landeira, J., Torra, A., Vila, M., & Bové, J.
- Affiliations
- Biomedical Research Networking Center on Neurodegenerative Diseases (ES)
- Institució Catalana de Recerca i Estudis Avançats (ES)
- Corresponding author
- Bové, Jordi
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-10-29
- Volume
- 143
- Issue
- 12
- Pages
- 3717-3733
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W3096763885
- Cited by
- 267
- References
- 62
- Citations by year
- 2026: 43 · 2025: 51 · 2024: 64 · 2023: 46 · 2022: 42 · 2021: 20 · 2020: 1
- FWCI
- 11.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fondo de Investigación Sanitaria-Instituto de Salud Carlos III (PI15/01937, PI18/01894)
- European Union, and Pla Estratègic de Recerca i Innovació en salut-Departament de Salut Generalitat de Catalunya (SLT006/17/00258)
- Ministry of Economy and Competitiveness (SAF2016-77541-R)
- “la Caixa” Foundation (100010434, LCF/PR/HR17/52150003)
- Fondo de Investigación Sanitaria- Instituto de Salud Carlos III
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- CD8+ T cells, T cell infiltration, substantia nigra pars compacta, synucleinopathies, alpha-synuclein aggregation, dopaminergic neuron loss, incidental Lewy body disease, tissue-resident memory T cells, granzymes, interferon-gamma, adaptive immune response, neuroinflammation, cytotoxic T lymphocytes, presymptomatic disease
- MeSH terms
- Synucleinopathies, Aged, Aged, 80 and over, Brain, Cytotoxins, Female, Humans, Immunohistochemistry, Immunologic Surveillance, Male, Neurons, Parkinson Disease, Substantia Nigra, Cytokines, Cell Death, CD8-Positive T-Lymphocytes, Disease Progression, Lewy Body Disease, alpha-Synuclein, Granzymes, Dopaminergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.